0.8846
price up icon1.50%   0.0131
 
loading
Equillium Inc stock is traded at $0.8846, with a volume of 193.84K. It is up +1.50% in the last 24 hours and down -38.57% over the past month. Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
See More
Previous Close:
$0.8715
Open:
$0.89
24h Volume:
193.84K
Relative Volume:
0.26
Market Cap:
$53.87M
Revenue:
$45.91M
Net Income/Loss:
$-4.62M
P/E Ratio:
-6.3096
EPS:
-0.1402
Net Cash Flow:
$-21.51M
1W Performance:
-13.27%
1M Performance:
-38.57%
6M Performance:
+139.73%
1Y Performance:
+23.03%
1-Day Range:
Value
$0.87
$0.9176
1-Week Range:
Value
$0.812
$0.9966
52-Week Range:
Value
$0.27
$2.35

Equillium Inc Stock (EQ) Company Profile

Name
Name
Equillium Inc
Name
Phone
(858) 412-5302
Name
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Name
Employee
35
Name
Twitter
Name
Next Earnings Date
2025-08-18
Name
Latest SEC Filings
Name
EQ's Discussions on Twitter

Compare EQ with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
EQ
Equillium Inc
0.8846 53.07M 45.91M -4.62M -21.51M -0.1402
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.26 117.50B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
722.83 76.06B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.56 62.53B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
916.31 56.75B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
205.04 44.10B 447.02M -1.18B -906.14M -6.1812

Equillium Inc Stock (EQ) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-28-25 Downgrade Leerink Partners Outperform → Market Perform
Oct-29-21 Resumed Stifel Buy
Sep-15-21 Initiated Cantor Fitzgerald Overweight
Jul-14-20 Reiterated H.C. Wainwright Buy
Jul-10-20 Resumed Stifel Buy
Feb-22-19 Initiated SVB Leerink Outperform
View All

Equillium Inc Stock (EQ) Latest News

pulisher
03:00 AM

Can Equillium Inc. (0FY) stock survive global slowdownTrend Reversal & Consistent Growth Stock Picks - Newser

03:00 AM
pulisher
02:41 AM

Can Equillium Inc. stock maintain growth trajectory2025 Big Picture & Growth Oriented Trade Recommendations - Newser

02:41 AM
pulisher
01:38 AM

Will Equillium Inc. stock deliver shareholder valueQuarterly Earnings Report & Fast Exit and Entry Trade Guides - Newser

01:38 AM
pulisher
Dec 04, 2025

Equillium Inc (EQ) can make a big difference with a little luck - Setenews

Dec 04, 2025
pulisher
Dec 04, 2025

Will Equillium Inc. (0FY) stock outperform small cap peersJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

How Equillium Inc. (0FY) stock expands through international marketsJuly 2025 Retail & Daily Chart Pattern Signals - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

What technical patterns form on Equillium Inc. (0FY) stock chartsEarnings Growth Report & Long-Term Growth Portfolio Plans - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

What hedge fund activity signals for Equillium Inc. stockJuly 2025 Sector Moves & Short-Term High Return Ideas - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Will Equillium Inc. (0FY) stock outperform global peersGold Moves & Verified Momentum Stock Alerts - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Why Equillium Inc. (0FY) stock could rally stronglyJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Is Equillium Inc. (0FY) stock at risk of policy regulationJobs Report & Technical Pattern Based Buy Signals - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Can Equillium Inc. (0FY) stock attract analyst upgradesEarnings Recap Report & Verified Chart Pattern Signals - Newser

Dec 02, 2025
pulisher
Nov 29, 2025

Market Fear: Can Equillium Inc. stock sustain free cash flow growthJuly 2025 Drop Watch & Technical Buy Zone Confirmation - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 28, 2025

Equillium Inc. (EQ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 28, 2025
pulisher
Nov 26, 2025

Equillium, Inc. (0A4D.L) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 26, 2025
pulisher
Nov 25, 2025

Equillium SVP Zedelmayer sells $7.7k in stock By Investing.com - Investing.com Australia

Nov 25, 2025
pulisher
Nov 25, 2025

Equillium SVP Zedelmayer sells $7.7k in stock - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

COO Zedelmayer Sells 8,098 ($7.7K) Of Equillium Inc [EQ] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

[Form 4] Equillium, Inc. Insider Trading Activity - Stock Titan

Nov 25, 2025
pulisher
Nov 25, 2025

COO Zedelmayer Files To Sell 8,098 Of Equillium Inc [EQ] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

Healthy Upside Potential: Equillium Inc (EQ) - Setenews

Nov 25, 2025
pulisher
Nov 24, 2025

Equillium Reports Q3 Loss Amid Strategic Focus - MSN

Nov 24, 2025
pulisher
Nov 21, 2025

Why Equillium Inc. (0FY) stock remains top ratedDividend Hike & Real-Time Stock Entry Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Equillium Inc. stock performs in weak economy2025 Market Outlook & Smart Swing Trading Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Equillium Inc. stock performs in rising dollar environmentWatch List & Trade Opportunity Analysis - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How buybacks impact Equillium Inc. stock valueJuly 2025 Sector Moves & Verified Short-Term Plans - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

How Equillium Inc. stock performs during Fed tightening cyclesAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Equillium, Inc. to Participate in Upcoming Investor Conferences in December 2025 - Quiver Quantitative

Nov 20, 2025
pulisher
Nov 20, 2025

Equillium to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 20, 2025
pulisher
Nov 20, 2025

Equillium (Nasdaq: EQ) to Present at Piper Sandler and Evercore ISI Healthcare Conferences - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Volatility clustering patterns for Equillium Inc.July 2025 Decliners & Smart Investment Allocation Insights - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Equillium Inc. (0FY) stock worth buying before Fed actionWeekly Risk Summary & Daily Profit Focused Screening - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Tick level data insight on Equillium Inc. volatilityMarket Movers & Accurate Intraday Trade Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Equillium Inc. (0FY) stock beat revenue estimatesWeekly Trade Summary & Community Consensus Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Equillium Inc. (0FY) stock split increase liquidityPrice Action & Stock Market Timing Techniques - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using Ichimoku Cloud for Equillium Inc. technicals2025 Market Trends & Verified Trade Idea Suggestions - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 16:28:35 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can a trend reversal in Equillium Inc. lead to recoveryQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Applying chart zones and confluence areas to Equillium Inc.Earnings Performance Report & Accurate Buy Signal Notifications - newser.com

Nov 19, 2025

Equillium Inc Stock (EQ) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
Cap:     |  Volume (24h):